CYSTIC Fibrosis Australia has used
a 65 Roses Day event in Parliament
House Canberra to again lobby
the manufacturer of the medicine
Kalydeco, Vertex Pharmaceuticals,
and government to fund the
product on the Pharmaceutical
Benefits Scheme (PD 11 Feb).
Cystic Fibrosis Australia ceo
Michelle Skinner said Budget
Papers had shown savings to the
PBS during the 2014/15 financial
year of $2.07b.
“The PBAC has recommended
Kalydeco on two occasions, but
the Department and the company
are haggling over price and patient
numbers.”
Without a subsidy, the annual
cost of Kalydeco exceeds $250,000.The above article was sent to subscribers in Pharmacy Daily's issue from 28 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 May 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.